カテゴリー： 世界, 医療/バイオ, LP Information

世界のフマル酸ベダキリン錠市場予測 2023年-2029年

【英語タイトル】Global Bedaquiline Fumarate Tablets Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC02801）・商品コード：LP23DC02801
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：72
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のフマル酸ベダキリン錠市場」は、過去の販売実績から2022年の世界のフマル酸ベダキリン錠の総販売量を検討し、2023年から2029年の予測されるフマル酸ベダキリン錠の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のフマル酸ベダキリン錠の市場規模を掲載し、XXX百万米ドル規模の世界のフマル酸ベダキリン錠市場の詳細な分析を提供します。本インサイトレポートは、世界のフマル酸ベダキリン錠業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のフマル酸ベダキリン錠市場における各社の独自のポジションをより深く理解するために、フマル酸ベダキリン錠製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のフマル酸ベダキリン錠市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。フマル酸ベダキリン錠の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。フマル酸ベダキリン錠の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。フマル酸ベダキリン錠のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

フマル酸ベダキリン錠の世界主要メーカーとしては、Janssen Therap、 Recipharm Pharmaservices、 Simcere Pharmaceutical、 Beijing Winsunny Pharmaceuticalなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のフマル酸ベダキリン錠市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではフマル酸ベダキリン錠市場をセグメンテーションし、種類別 (100 mg、その他)、用途別 (病院、診療所、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：100 mg、その他

・用途別区分：病院、診療所、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のフマル酸ベダキリン錠市場の10年間の市場状況・展望は？
・世界および地域別に見たフマル酸ベダキリン錠市場成長の要因は何か？
・フマル酸ベダキリン錠の市場機会はエンドマーケットの規模によってどのように変化するのか？
・フマル酸ベダキリン錠のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：フマル酸ベダキリン錠の年間販売量2018-2029、地域別現状・将来分析
・フマル酸ベダキリン錠の種類別セグメント：100 mg、その他
・フマル酸ベダキリン錠の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・フマル酸ベダキリン錠の用途別セグメント：病院、診療所、その他
・フマル酸ベダキリン錠の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のフマル酸ベダキリン錠市場
・企業別のグローバルフマル酸ベダキリン錠市場データ：2018-2023年の年間販売量、市場シェア
・企業別のフマル酸ベダキリン錠の年間売上：2018-2023年の売上、市場シェア
・企業別のフマル酸ベダキリン錠販売価格
・主要企業のフマル酸ベダキリン錠生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

フマル酸ベダキリン錠の地域別レビュー
・地域別のフマル酸ベダキリン錠市場規模2018-2023：年間販売量、売上
・主要国別のフマル酸ベダキリン錠市場規模2018-2023：年間販売量、売上
・南北アメリカのフマル酸ベダキリン錠販売の成長
・アジア太平洋のフマル酸ベダキリン錠販売の成長
・ヨーロッパのフマル酸ベダキリン錠販売の成長
・中東・アフリカのフマル酸ベダキリン錠販売の成長

南北アメリカ市場
・南北アメリカの国別のフマル酸ベダキリン錠販売量、売上（2018-2023）
・南北アメリカのフマル酸ベダキリン錠の種類別販売量
・南北アメリカのフマル酸ベダキリン錠の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のフマル酸ベダキリン錠販売量、売上（2018-2023）
・アジア太平洋のフマル酸ベダキリン錠の種類別販売量
・アジア太平洋のフマル酸ベダキリン錠の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のフマル酸ベダキリン錠販売量、売上（2018-2023）
・ヨーロッパのフマル酸ベダキリン錠の種類別販売量
・ヨーロッパのフマル酸ベダキリン錠の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のフマル酸ベダキリン錠販売量、売上（2018-2023）
・中東・アフリカのフマル酸ベダキリン錠の種類別販売量
・中東・アフリカのフマル酸ベダキリン錠の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・フマル酸ベダキリン錠の製造コスト構造分析
・フマル酸ベダキリン錠の製造プロセス分析
・フマル酸ベダキリン錠の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・フマル酸ベダキリン錠の主要なグローバル販売業者
・フマル酸ベダキリン錠の主要なグローバル顧客

地域別のフマル酸ベダキリン錠市場予測レビュー
・地域別のフマル酸ベダキリン錠市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・フマル酸ベダキリン錠の種類別市場規模予測
・フマル酸ベダキリン錠の用途別市場規模予測

主要企業分析
Janssen Therap、 Recipharm Pharmaservices、 Simcere Pharmaceutical、 Beijing Winsunny Pharmaceutical
・企業情報
・フマル酸ベダキリン錠製品
・フマル酸ベダキリン錠販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Bedaquiline Fumarate Tablets market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Bedaquiline Fumarate Tablets is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Bedaquiline Fumarate Tablets is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Bedaquiline Fumarate Tablets is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Bedaquiline Fumarate Tablets players cover Janssen Therap, Recipharm Pharmaservices, Simcere Pharmaceutical and Beijing Winsunny Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Bedaquiline Fumarate Tablets Industry Forecast” looks at past sales and reviews total world Bedaquiline Fumarate Tablets sales in 2022, providing a comprehensive analysis by region and market sector of projected Bedaquiline Fumarate Tablets sales for 2023 through 2029. With Bedaquiline Fumarate Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bedaquiline Fumarate Tablets industry.
This Insight Report provides a comprehensive analysis of the global Bedaquiline Fumarate Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bedaquiline Fumarate Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bedaquiline Fumarate Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bedaquiline Fumarate Tablets and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bedaquiline Fumarate Tablets.
This report presents a comprehensive overview, market shares, and growth opportunities of Bedaquiline Fumarate Tablets market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
100 mg
Other
Segmentation by application
Hospital
Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Janssen Therap
Recipharm Pharmaservices
Simcere Pharmaceutical
Beijing Winsunny Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Bedaquiline Fumarate Tablets market?
What factors are driving Bedaquiline Fumarate Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Bedaquiline Fumarate Tablets market opportunities vary by end market size?
How does Bedaquiline Fumarate Tablets break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bedaquiline Fumarate Tablets Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Bedaquiline Fumarate Tablets by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Bedaquiline Fumarate Tablets by Country/Region, 2018, 2022 & 2029
2.2 Bedaquiline Fumarate Tablets Segment by Type
2.2.1 100 mg
2.2.2 Other
2.3 Bedaquiline Fumarate Tablets Sales by Type
2.3.1 Global Bedaquiline Fumarate Tablets Sales Market Share by Type (2018-2023)
2.3.2 Global Bedaquiline Fumarate Tablets Revenue and Market Share by Type (2018-2023)
2.3.3 Global Bedaquiline Fumarate Tablets Sale Price by Type (2018-2023)
2.4 Bedaquiline Fumarate Tablets Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Bedaquiline Fumarate Tablets Sales by Application
2.5.1 Global Bedaquiline Fumarate Tablets Sale Market Share by Application (2018-2023)
2.5.2 Global Bedaquiline Fumarate Tablets Revenue and Market Share by Application (2018-2023)
2.5.3 Global Bedaquiline Fumarate Tablets Sale Price by Application (2018-2023)
3 Global Bedaquiline Fumarate Tablets by Company
3.1 Global Bedaquiline Fumarate Tablets Breakdown Data by Company
3.1.1 Global Bedaquiline Fumarate Tablets Annual Sales by Company (2018-2023)
3.1.2 Global Bedaquiline Fumarate Tablets Sales Market Share by Company (2018-2023)
3.2 Global Bedaquiline Fumarate Tablets Annual Revenue by Company (2018-2023)
3.2.1 Global Bedaquiline Fumarate Tablets Revenue by Company (2018-2023)
3.2.2 Global Bedaquiline Fumarate Tablets Revenue Market Share by Company (2018-2023)
3.3 Global Bedaquiline Fumarate Tablets Sale Price by Company
3.4 Key Manufacturers Bedaquiline Fumarate Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bedaquiline Fumarate Tablets Product Location Distribution
3.4.2 Players Bedaquiline Fumarate Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Bedaquiline Fumarate Tablets by Geographic Region
4.1 World Historic Bedaquiline Fumarate Tablets Market Size by Geographic Region (2018-2023)
4.1.1 Global Bedaquiline Fumarate Tablets Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Bedaquiline Fumarate Tablets Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Bedaquiline Fumarate Tablets Market Size by Country/Region (2018-2023)
4.2.1 Global Bedaquiline Fumarate Tablets Annual Sales by Country/Region (2018-2023)
4.2.2 Global Bedaquiline Fumarate Tablets Annual Revenue by Country/Region (2018-2023)
4.3 Americas Bedaquiline Fumarate Tablets Sales Growth
4.4 APAC Bedaquiline Fumarate Tablets Sales Growth
4.5 Europe Bedaquiline Fumarate Tablets Sales Growth
4.6 Middle East & Africa Bedaquiline Fumarate Tablets Sales Growth
5 Americas
5.1 Americas Bedaquiline Fumarate Tablets Sales by Country
5.1.1 Americas Bedaquiline Fumarate Tablets Sales by Country (2018-2023)
5.1.2 Americas Bedaquiline Fumarate Tablets Revenue by Country (2018-2023)
5.2 Americas Bedaquiline Fumarate Tablets Sales by Type
5.3 Americas Bedaquiline Fumarate Tablets Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bedaquiline Fumarate Tablets Sales by Region
6.1.1 APAC Bedaquiline Fumarate Tablets Sales by Region (2018-2023)
6.1.2 APAC Bedaquiline Fumarate Tablets Revenue by Region (2018-2023)
6.2 APAC Bedaquiline Fumarate Tablets Sales by Type
6.3 APAC Bedaquiline Fumarate Tablets Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Bedaquiline Fumarate Tablets by Country
7.1.1 Europe Bedaquiline Fumarate Tablets Sales by Country (2018-2023)
7.1.2 Europe Bedaquiline Fumarate Tablets Revenue by Country (2018-2023)
7.2 Europe Bedaquiline Fumarate Tablets Sales by Type
7.3 Europe Bedaquiline Fumarate Tablets Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bedaquiline Fumarate Tablets by Country
8.1.1 Middle East & Africa Bedaquiline Fumarate Tablets Sales by Country (2018-2023)
8.1.2 Middle East & Africa Bedaquiline Fumarate Tablets Revenue by Country (2018-2023)
8.2 Middle East & Africa Bedaquiline Fumarate Tablets Sales by Type
8.3 Middle East & Africa Bedaquiline Fumarate Tablets Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bedaquiline Fumarate Tablets
10.3 Manufacturing Process Analysis of Bedaquiline Fumarate Tablets
10.4 Industry Chain Structure of Bedaquiline Fumarate Tablets
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bedaquiline Fumarate Tablets Distributors
11.3 Bedaquiline Fumarate Tablets Customer
12 World Forecast Review for Bedaquiline Fumarate Tablets by Geographic Region
12.1 Global Bedaquiline Fumarate Tablets Market Size Forecast by Region
12.1.1 Global Bedaquiline Fumarate Tablets Forecast by Region (2024-2029)
12.1.2 Global Bedaquiline Fumarate Tablets Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Bedaquiline Fumarate Tablets Forecast by Type
12.7 Global Bedaquiline Fumarate Tablets Forecast by Application
13 Key Players Analysis
13.1 Janssen Therap
13.1.1 Janssen Therap Company Information
13.1.2 Janssen Therap Bedaquiline Fumarate Tablets Product Portfolios and Specifications
13.1.3 Janssen Therap Bedaquiline Fumarate Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Janssen Therap Main Business Overview
13.1.5 Janssen Therap Latest Developments
13.2 Recipharm Pharmaservices
13.2.1 Recipharm Pharmaservices Company Information
13.2.2 Recipharm Pharmaservices Bedaquiline Fumarate Tablets Product Portfolios and Specifications
13.2.3 Recipharm Pharmaservices Bedaquiline Fumarate Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Recipharm Pharmaservices Main Business Overview
13.2.5 Recipharm Pharmaservices Latest Developments
13.3 Simcere Pharmaceutical
13.3.1 Simcere Pharmaceutical Company Information
13.3.2 Simcere Pharmaceutical Bedaquiline Fumarate Tablets Product Portfolios and Specifications
13.3.3 Simcere Pharmaceutical Bedaquiline Fumarate Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Simcere Pharmaceutical Main Business Overview
13.3.5 Simcere Pharmaceutical Latest Developments
13.4 Beijing Winsunny Pharmaceutical
13.4.1 Beijing Winsunny Pharmaceutical Company Information
13.4.2 Beijing Winsunny Pharmaceutical Bedaquiline Fumarate Tablets Product Portfolios and Specifications
13.4.3 Beijing Winsunny Pharmaceutical Bedaquiline Fumarate Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Beijing Winsunny Pharmaceutical Main Business Overview
13.4.5 Beijing Winsunny Pharmaceutical Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Bedaquiline Fumarate Tablets Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Bedaquiline Fumarate Tablets Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 100 mg
Table 4. Major Players of Other
Table 5. Global Bedaquiline Fumarate Tablets Sales by Type (2018-2023) & (Tons)
Table 6. Global Bedaquiline Fumarate Tablets Sales Market Share by Type (2018-2023)
Table 7. Global Bedaquiline Fumarate Tablets Revenue by Type (2018-2023) & ($ million)
Table 8. Global Bedaquiline Fumarate Tablets Revenue Market Share by Type (2018-2023)
Table 9. Global Bedaquiline Fumarate Tablets Sale Price by Type (2018-2023) & (US$/Ton)
Table 10. Global Bedaquiline Fumarate Tablets Sales by Application (2018-2023) & (Tons)
Table 11. Global Bedaquiline Fumarate Tablets Sales Market Share by Application (2018-2023)
Table 12. Global Bedaquiline Fumarate Tablets Revenue by Application (2018-2023)
Table 13. Global Bedaquiline Fumarate Tablets Revenue Market Share by Application (2018-2023)
Table 14. Global Bedaquiline Fumarate Tablets Sale Price by Application (2018-2023) & (US$/Ton)
Table 15. Global Bedaquiline Fumarate Tablets Sales by Company (2018-2023) & (Tons)
Table 16. Global Bedaquiline Fumarate Tablets Sales Market Share by Company (2018-2023)
Table 17. Global Bedaquiline Fumarate Tablets Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Bedaquiline Fumarate Tablets Revenue Market Share by Company (2018-2023)
Table 19. Global Bedaquiline Fumarate Tablets Sale Price by Company (2018-2023) & (US$/Ton)
Table 20. Key Manufacturers Bedaquiline Fumarate Tablets Producing Area Distribution and Sales Area
Table 21. Players Bedaquiline Fumarate Tablets Products Offered
Table 22. Bedaquiline Fumarate Tablets Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Bedaquiline Fumarate Tablets Sales by Geographic Region (2018-2023) & (Tons)
Table 26. Global Bedaquiline Fumarate Tablets Sales Market Share Geographic Region (2018-2023)
Table 27. Global Bedaquiline Fumarate Tablets Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Bedaquiline Fumarate Tablets Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Bedaquiline Fumarate Tablets Sales by Country/Region (2018-2023) & (Tons)
Table 30. Global Bedaquiline Fumarate Tablets Sales Market Share by Country/Region (2018-2023)
Table 31. Global Bedaquiline Fumarate Tablets Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Bedaquiline Fumarate Tablets Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Bedaquiline Fumarate Tablets Sales by Country (2018-2023) & (Tons)
Table 34. Americas Bedaquiline Fumarate Tablets Sales Market Share by Country (2018-2023)
Table 35. Americas Bedaquiline Fumarate Tablets Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Bedaquiline Fumarate Tablets Revenue Market Share by Country (2018-2023)
Table 37. Americas Bedaquiline Fumarate Tablets Sales by Type (2018-2023) & (Tons)
Table 38. Americas Bedaquiline Fumarate Tablets Sales by Application (2018-2023) & (Tons)
Table 39. APAC Bedaquiline Fumarate Tablets Sales by Region (2018-2023) & (Tons)
Table 40. APAC Bedaquiline Fumarate Tablets Sales Market Share by Region (2018-2023)
Table 41. APAC Bedaquiline Fumarate Tablets Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Bedaquiline Fumarate Tablets Revenue Market Share by Region (2018-2023)
Table 43. APAC Bedaquiline Fumarate Tablets Sales by Type (2018-2023) & (Tons)
Table 44. APAC Bedaquiline Fumarate Tablets Sales by Application (2018-2023) & (Tons)
Table 45. Europe Bedaquiline Fumarate Tablets Sales by Country (2018-2023) & (Tons)
Table 46. Europe Bedaquiline Fumarate Tablets Sales Market Share by Country (2018-2023)
Table 47. Europe Bedaquiline Fumarate Tablets Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Bedaquiline Fumarate Tablets Revenue Market Share by Country (2018-2023)
Table 49. Europe Bedaquiline Fumarate Tablets Sales by Type (2018-2023) & (Tons)
Table 50. Europe Bedaquiline Fumarate Tablets Sales by Application (2018-2023) & (Tons)
Table 51. Middle East & Africa Bedaquiline Fumarate Tablets Sales by Country (2018-2023) & (Tons)
Table 52. Middle East & Africa Bedaquiline Fumarate Tablets Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Bedaquiline Fumarate Tablets Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Bedaquiline Fumarate Tablets Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Bedaquiline Fumarate Tablets Sales by Type (2018-2023) & (Tons)
Table 56. Middle East & Africa Bedaquiline Fumarate Tablets Sales by Application (2018-2023) & (Tons)
Table 57. Key Market Drivers & Growth Opportunities of Bedaquiline Fumarate Tablets
Table 58. Key Market Challenges & Risks of Bedaquiline Fumarate Tablets
Table 59. Key Industry Trends of Bedaquiline Fumarate Tablets
Table 60. Bedaquiline Fumarate Tablets Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Bedaquiline Fumarate Tablets Distributors List
Table 63. Bedaquiline Fumarate Tablets Customer List
Table 64. Global Bedaquiline Fumarate Tablets Sales Forecast by Region (2024-2029) & (Tons)
Table 65. Global Bedaquiline Fumarate Tablets Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Bedaquiline Fumarate Tablets Sales Forecast by Country (2024-2029) & (Tons)
Table 67. Americas Bedaquiline Fumarate Tablets Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Bedaquiline Fumarate Tablets Sales Forecast by Region (2024-2029) & (Tons)
Table 69. APAC Bedaquiline Fumarate Tablets Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Bedaquiline Fumarate Tablets Sales Forecast by Country (2024-2029) & (Tons)
Table 71. Europe Bedaquiline Fumarate Tablets Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Bedaquiline Fumarate Tablets Sales Forecast by Country (2024-2029) & (Tons)
Table 73. Middle East & Africa Bedaquiline Fumarate Tablets Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Bedaquiline Fumarate Tablets Sales Forecast by Type (2024-2029) & (Tons)
Table 75. Global Bedaquiline Fumarate Tablets Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Bedaquiline Fumarate Tablets Sales Forecast by Application (2024-2029) & (Tons)
Table 77. Global Bedaquiline Fumarate Tablets Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Janssen Therap Basic Information, Bedaquiline Fumarate Tablets Manufacturing Base, Sales Area and Its Competitors
Table 79. Janssen Therap Bedaquiline Fumarate Tablets Product Portfolios and Specifications
Table 80. Janssen Therap Bedaquiline Fumarate Tablets Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 81. Janssen Therap Main Business
Table 82. Janssen Therap Latest Developments
Table 83. Recipharm Pharmaservices Basic Information, Bedaquiline Fumarate Tablets Manufacturing Base, Sales Area and Its Competitors
Table 84. Recipharm Pharmaservices Bedaquiline Fumarate Tablets Product Portfolios and Specifications
Table 85. Recipharm Pharmaservices Bedaquiline Fumarate Tablets Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 86. Recipharm Pharmaservices Main Business
Table 87. Recipharm Pharmaservices Latest Developments
Table 88. Simcere Pharmaceutical Basic Information, Bedaquiline Fumarate Tablets Manufacturing Base, Sales Area and Its Competitors
Table 89. Simcere Pharmaceutical Bedaquiline Fumarate Tablets Product Portfolios and Specifications
Table 90. Simcere Pharmaceutical Bedaquiline Fumarate Tablets Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 91. Simcere Pharmaceutical Main Business
Table 92. Simcere Pharmaceutical Latest Developments
Table 93. Beijing Winsunny Pharmaceutical Basic Information, Bedaquiline Fumarate Tablets Manufacturing Base, Sales Area and Its Competitors
Table 94. Beijing Winsunny Pharmaceutical Bedaquiline Fumarate Tablets Product Portfolios and Specifications
Table 95. Beijing Winsunny Pharmaceutical Bedaquiline Fumarate Tablets Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 96. Beijing Winsunny Pharmaceutical Main Business
Table 97. Beijing Winsunny Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Bedaquiline Fumarate Tablets
Figure 2. Bedaquiline Fumarate Tablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Bedaquiline Fumarate Tablets Sales Growth Rate 2018-2029 (Tons)
Figure 7. Global Bedaquiline Fumarate Tablets Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Bedaquiline Fumarate Tablets Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 100 mg
Figure 10. Product Picture of Other
Figure 11. Global Bedaquiline Fumarate Tablets Sales Market Share by Type in 2022
Figure 12. Global Bedaquiline Fumarate Tablets Revenue Market Share by Type (2018-2023)
Figure 13. Bedaquiline Fumarate Tablets Consumed in Hospital
Figure 14. Global Bedaquiline Fumarate Tablets Market: Hospital (2018-2023) & (Tons)
Figure 15. Bedaquiline Fumarate Tablets Consumed in Clinic
Figure 16. Global Bedaquiline Fumarate Tablets Market: Clinic (2018-2023) & (Tons)
Figure 17. Bedaquiline Fumarate Tablets Consumed in Other
Figure 18. Global Bedaquiline Fumarate Tablets Market: Other (2018-2023) & (Tons)
Figure 19. Global Bedaquiline Fumarate Tablets Sales Market Share by Application (2022)
Figure 20. Global Bedaquiline Fumarate Tablets Revenue Market Share by Application in 2022
Figure 21. Bedaquiline Fumarate Tablets Sales Market by Company in 2022 (Tons)
Figure 22. Global Bedaquiline Fumarate Tablets Sales Market Share by Company in 2022
Figure 23. Bedaquiline Fumarate Tablets Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Bedaquiline Fumarate Tablets Revenue Market Share by Company in 2022
Figure 25. Global Bedaquiline Fumarate Tablets Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Bedaquiline Fumarate Tablets Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Bedaquiline Fumarate Tablets Sales 2018-2023 (Tons)
Figure 28. Americas Bedaquiline Fumarate Tablets Revenue 2018-2023 ($ Millions)
Figure 29. APAC Bedaquiline Fumarate Tablets Sales 2018-2023 (Tons)
Figure 30. APAC Bedaquiline Fumarate Tablets Revenue 2018-2023 ($ Millions)
Figure 31. Europe Bedaquiline Fumarate Tablets Sales 2018-2023 (Tons)
Figure 32. Europe Bedaquiline Fumarate Tablets Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Bedaquiline Fumarate Tablets Sales 2018-2023 (Tons)
Figure 34. Middle East & Africa Bedaquiline Fumarate Tablets Revenue 2018-2023 ($ Millions)
Figure 35. Americas Bedaquiline Fumarate Tablets Sales Market Share by Country in 2022
Figure 36. Americas Bedaquiline Fumarate Tablets Revenue Market Share by Country in 2022
Figure 37. Americas Bedaquiline Fumarate Tablets Sales Market Share by Type (2018-2023)
Figure 38. Americas Bedaquiline Fumarate Tablets Sales Market Share by Application (2018-2023)
Figure 39. United States Bedaquiline Fumarate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Bedaquiline Fumarate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Bedaquiline Fumarate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Bedaquiline Fumarate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Bedaquiline Fumarate Tablets Sales Market Share by Region in 2022
Figure 44. APAC Bedaquiline Fumarate Tablets Revenue Market Share by Regions in 2022
Figure 45. APAC Bedaquiline Fumarate Tablets Sales Market Share by Type (2018-2023)
Figure 46. APAC Bedaquiline Fumarate Tablets Sales Market Share by Application (2018-2023)
Figure 47. China Bedaquiline Fumarate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Bedaquiline Fumarate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Bedaquiline Fumarate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Bedaquiline Fumarate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Bedaquiline Fumarate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Bedaquiline Fumarate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Bedaquiline Fumarate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Bedaquiline Fumarate Tablets Sales Market Share by Country in 2022
Figure 55. Europe Bedaquiline Fumarate Tablets Revenue Market Share by Country in 2022
Figure 56. Europe Bedaquiline Fumarate Tablets Sales Market Share by Type (2018-2023)
Figure 57. Europe Bedaquiline Fumarate Tablets Sales Market Share by Application (2018-2023)
Figure 58. Germany Bedaquiline Fumarate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Bedaquiline Fumarate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Bedaquiline Fumarate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Bedaquiline Fumarate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Bedaquiline Fumarate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Bedaquiline Fumarate Tablets Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Bedaquiline Fumarate Tablets Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Bedaquiline Fumarate Tablets Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Bedaquiline Fumarate Tablets Sales Market Share by Application (2018-2023)
Figure 67. Egypt Bedaquiline Fumarate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Bedaquiline Fumarate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Bedaquiline Fumarate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Bedaquiline Fumarate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Bedaquiline Fumarate Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Bedaquiline Fumarate Tablets in 2022
Figure 73. Manufacturing Process Analysis of Bedaquiline Fumarate Tablets
Figure 74. Industry Chain Structure of Bedaquiline Fumarate Tablets
Figure 75. Channels of Distribution
Figure 76. Global Bedaquiline Fumarate Tablets Sales Market Forecast by Region (2024-2029)
Figure 77. Global Bedaquiline Fumarate Tablets Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Bedaquiline Fumarate Tablets Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Bedaquiline Fumarate Tablets Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Bedaquiline Fumarate Tablets Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Bedaquiline Fumarate Tablets Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のフマル酸ベダキリン錠市場予測 2023年-2029年] (コード：LP23DC02801)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のフマル酸ベダキリン錠市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の医薬品用フマル酸ボノプラザン市場予測 2023年-2029年
  • 世界の医薬品用フマル酸ジメチル市場予測 2023年-2029年
  • 世界のシャオシュアン銅鑼錠市場予測 2023年-2029年
  • 世界のプラミペキソール二塩酸塩錠市場予測 2023年-2029年
  • 世界のゾピクロン錠市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆